AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (March 7, 2002). doi:10.1152/ajpheart.00022.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/1/H315    most recent
00022.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niwa, K.
Right arrow Articles by Iadecola, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Niwa, K.
Right arrow Articles by Iadecola, C.

Articles in PresS, published online ahead of print March 7, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00022.2002
Submitted on January 14, 2002
Accepted on March 4, 2002

Cerebrovascular autoregulation is profoundly impaired in mice overexpressing the amyloid precursor protein

Kiyoshi Niwa1, Ken Kazama1, Linda Younkin2, Steven G Younkin2, Carlson A George3, and Costantino Iadecola1*

1 Neurology, University of Minnesota, Minneapolis, MN, USA
2 Mayo Clinic Jacksonville, Jacksonville, FL, USA
3 McLaughlin Reseach Insitute, Great Falls, MT, USA

* To whom correspondence should be addressed. E-mail: iadec001{at}umn.edu.

The Aß peptide, derived from the amyloid precursor protein (APP), is involved in the pathogenesis of Alzheimer's dementia and impairs endothelium-dependent vasodilation in cerebral vessels. We investigated whether cerebrovascular autoregulation, i.e., the ability of the cerebral circulation to maintain flow in the face of changes in mean arterial pressure (MAP), is impaired in transgenic mice overexpressing APP and Aß. Neocortical cerebral blood flow (CBF) was monitored by laser-Doppler flowmetry in anesthetized APP+ and APP- mice. MAP was elevated by i.v. infusion of phenylephrine and reduced by controlled exanguination. In APP- mice autoregulation was preserved. However, in APP+ mice, autoregulation was markedly disrupted. The magnitude of the disruption was linearly related to brain Aß concentration. The failure of autoregulation was paralleled by impairment of the CBF response to endothelium-dependent vasodilators. Thus, Aß disrupts a critical homeostatic mechanism of the cerebral circulation and renders CBF highly dependent on MAP. The resulting alterations in cerebral perfusion may play a role in the brain dysfunction and periventricular white matter changes associated with Alzheimer's dementia.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
B. H. Han, M.-l. Zhou, F. Abousaleh, R. P. Brendza, H. H. Dietrich, J. Koenigsknecht-Talboo, J. R. Cirrito, E. Milner, D. M. Holtzman, and G. J. Zipfel
Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-{beta} Peptide, Partial Restoration via {gamma}-Secretase Inhibition
J. Neurosci., December 10, 2008; 28(50): 13542 - 13550.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. E. Smith, M. Vijayappa, F. Lima, P. Delgado, L. Wendell, J. Rosand, and S. M. Greenberg
Impaired visual evoked flow velocity response in cerebral amyloid angiopathy
Neurology, October 28, 2008; 71(18): 1424 - 1430.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Nicolakakis, T. Aboulkassim, B. Ongali, C. Lecrux, P. Fernandes, P. Rosa-Neto, X.-K. Tong, and E. Hamel
Complete Rescue of Cerebrovascular Function in Aged Alzheimer's Disease Transgenic Mice by Antioxidants and Pioglitazone, a Peroxisome Proliferator-Activated Receptor {gamma} Agonist
J. Neurosci., September 10, 2008; 28(37): 9287 - 9296.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Park, P. Zhou, R. Pitstick, C. Capone, J. Anrather, E. H. Norris, L. Younkin, S. Younkin, G. Carlson, B. S. McEwen, et al.
Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein
PNAS, January 29, 2008; 105(4): 1347 - 1352.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
E. Hamel, N. Nicolakakis, T. Aboulkassim, B. Ongali, and X-K. Tong
Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease
Exp Physiol, January 1, 2008; 93(1): 116 - 120.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
H. K. Shin, P. B. Jones, M. Garcia-Alloza, L. Borrelli, S. M. Greenberg, B. J. Bacskai, M. P. Frosch, B. T. Hyman, M. A. Moskowitz, and C. Ayata
Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy
Brain, September 1, 2007; 130(9): 2310 - 2319.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H. Girouard and C. Iadecola
Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease
J Appl Physiol, January 1, 2006; 100(1): 328 - 335.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X.-K. Tong, N. Nicolakakis, A. Kocharyan, and E. Hamel
Vascular Remodeling versus Amyloid {beta}-Induced Oxidative Stress in the Cerebrovascular Dysfunctions Associated with Alzheimer's Disease
J. Neurosci., November 30, 2005; 25(48): 11165 - 11174.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Park, J. Anrather, P. Zhou, K. Frys, R. Pitstick, S. Younkin, G. A. Carlson, and C. Iadecola
NADPH Oxidase-Derived Reactive Oxygen Species Mediate the Cerebrovascular Dysfunction Induced by the Amyloid {beta} Peptide
J. Neurosci., February 16, 2005; 25(7): 1769 - 1777.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Krezowski, D. Knudson, C. Ebeling, R. Pitstick, R. K. Giri, D. Schenk, D. Westaway, L. Younkin, S. G. Younkin, K. H. Ashe, et al.
Identification of loci determining susceptibility to the lethal effects of amyloid precursor protein transgene overexpression
Hum. Mol. Genet., September 15, 2004; 13(18): 1989 - 1997.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Z. Suo, M. Wu, B. A. Citron, G. T. Wong, and B. W. Festoff
Abnormality of G-Protein-Coupled Receptor Kinases at Prodromal and Early Stages of Alzheimer's Disease: An Association with Early {beta}-Amyloid Accumulation
J. Neurosci., March 31, 2004; 24(13): 3444 - 3452.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Iadecola
Atherosclerosis and Neurodegeneration: Unexpected Conspirators in Alzheimer's Dementia
Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 1951 - 1953.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. E. Roher, C. Esh, T. A. Kokjohn, W. Kalback, D. C. Luehrs, J. D. Seward, L. I. Sue, and T. G. Beach
Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer's Disease
Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2055 - 2062.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Mueggler, D. Baumann, M. Rausch, M. Staufenbiel, and M. Rudin
Age-Dependent Impairment of Somatosensory Response in the Amyloid Precursor Protein 23 Transgenic Mouse Model of Alzheimer's Disease
J. Neurosci., September 10, 2003; 23(23): 8231 - 8236.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Iadecola and P. B. Gorelick
Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia
Stroke, February 1, 2003; 34(2): 335 - 337.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.